首页 | 本学科首页   官方微博 | 高级检索  
     

瘢痕子宫应用米非司酮联合依沙吖啶中期引产的疗效分析
引用本文:周莉莉,刘月华. 瘢痕子宫应用米非司酮联合依沙吖啶中期引产的疗效分析[J]. 吉林医学, 2012, 0(1): 26-27
作者姓名:周莉莉  刘月华
作者单位:天津市河东区妇产科医院
摘    要:目的:探讨米非司酮联合依沙吖啶应用于瘢痕子宫中期妊娠引产的有效性和安全性。方法:将42例瘢痕子宫中期妊娠引产的妇女随机分成观察组和对照组,每组各21例。观察组先给予口服米非司酮200 mg,再行依沙吖啶羊膜腔内注射;对照组单行依沙吖啶羊膜腔内注射。结果:观察组与对照组总产程时间、产程发动时间、胎盘胎膜残留情况、产后出血量的比较,差异有统计学意义(P<0.05)。结论:米非司酮联合依沙吖啶用于瘢痕子宫中期妊娠是一种理想、安全、有效的引产方法。

关 键 词:米非司酮  依沙吖啶  瘢痕子宫  中期妊娠引产

Effects of mifepristone plus ethacridine in mid trimester of pregnancy induced labor in scar uterus
ZHOU Li-li,LIU Yue-hua. Effects of mifepristone plus ethacridine in mid trimester of pregnancy induced labor in scar uterus[J]. Jilin Medical Journal, 2012, 0(1): 26-27
Authors:ZHOU Li-li  LIU Yue-hua
Affiliation:(Tianjin Hedong Gynaecology and Obstetrics Hospital,Tianjin 300012,China)
Abstract:Objective To evaluate the efficacy and safety of mifepristone plus ethacridine in mid trimester of pregnancy induced labor in scar uterus.Method Total 42 cases of uterine scar trimester abortion women were randomly divided into the treatment group and the control group,21 patients in each group.The treatment group received oral mifepristone 200 mg,plused ethacridine amniotic injection;the control group with ethacridine single intra-amniotic injection.Results The total labor time,launch time of labor,placental membranes residue and the amount of postpartum hemorrhage in the treatment group and the control group showed significant difference(P<0.05).Conclusion Mifepristone plus ethacridine for trimester uterine scar is an ideal,safe and effective abortion method.
Keywords:Mifepristonel  Ethacridine  Uterine scar  Trimester abortion
本文献已被 CNKI 等数据库收录!
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号